Immunome, Inc. ("Immunome") (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class ...
Medline Inc. (“Medline”) announced today the pricing of its upsized initial public offering of 216,034,482 shares of its Class A common stock, at a public offering price of $29.00 per share. Medline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback